The ongoing legal battle over access to the abortion pill mifepristone has led to multiple actions from the Supreme Court and lower courts. Recently, the Supreme Court temporarily restored the ability for patients to receive the abortion pill by mail, reversing earlier decisions that had imposed significant restrictions on access. This comes as drugmakers and abortion rights advocates navigate new challenges, including appeals that have curtailed telehealth and mail-order options for mifepristone. The legal landscape remains uncertain as the court deals with emergency appeals and the implications of recent rulings, which have created a complex framework affecting abortion access nationwide. Notably, states are adapting to rapid changes, with some organizations shifting protocols in response to court decisions impacting prescription methods.